Found: 56
Select item for more details and to access through your institution.
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4421, doi. 10.3390/cancers13174421
- By:
- Publication type:
- Article
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3021, doi. 10.3390/cancers12103021
- By:
- Publication type:
- Article
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 10, doi. 10.3390/cancers11010010
- By:
- Publication type:
- Article
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.
- Published in:
- Clinical Research in Cardiology, 2020, v. 109, n. 10, p. 1197, doi. 10.1007/s00392-020-01636-7
- By:
- Publication type:
- Article
How detection of immune-related adverse events fails during transfer of patients between medical sectors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 15, p. 14465, doi. 10.1007/s00432-023-05203-1
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Breast Cancer: Current Limitations.
- Published in:
- Breast Journal, 2015, v. 21, n. 4, p. 450, doi. 10.1111/tbj.12431
- By:
- Publication type:
- Article
Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 5865, doi. 10.2147/OTT.S155438
- By:
- Publication type:
- Article
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00667-x
- By:
- Publication type:
- Article
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 319, doi. 10.1007/s10549-018-5008-3
- By:
- Publication type:
- Article
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 1, p. 59, doi. 10.1007/s10549-016-3850-8
- By:
- Publication type:
- Article
Vorwort.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, p. 1, doi. 10.1159/000501222
- By:
- Publication type:
- Article
Geheilt, aber nicht gesund: Das Problem der Langzeitnebenwirkungen.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, p. 14, doi. 10.1159/000500817
- By:
- Publication type:
- Article
Vorwort.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, p. 1, doi. 10.1159/000491683
- By:
- Publication type:
- Article
Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, p. 2, doi. 10.1159/000490082
- By:
- Publication type:
- Article
Vorwort.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, p. 1, doi. 10.1159/000448062
- By:
- Publication type:
- Article
Vorwort.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, p. 1, doi. 10.1159/000437006
- By:
- Publication type:
- Article
Vorwort.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, p. 1, doi. 10.1159/000369567
- By:
- Publication type:
- Article
Ausblick.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, p. 23, doi. 10.1159/000369568
- By:
- Publication type:
- Article
Benefits and Risks of Cancer Screening.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, p. 1, doi. 10.1159/000363456
- By:
- Publication type:
- Article
Vorwort.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, p. 1, doi. 10.1159/000353543
- By:
- Publication type:
- Article
Gezielte Therapie: alte und neue Hoffnungsträger.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, p. 2, doi. 10.1159/000351997
- By:
- Publication type:
- Article
Practical Management of Everolimus-Related Toxicities in Patients with Advanced Solid Tumors.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 5, p. 295, doi. 10.1159/000350625
- By:
- Publication type:
- Article
Efficacy and safety of a 2-tier prostaglandin labor induction Schedule.
- Published in:
- Journal of Perinatal Medicine, 1994, v. 22, n. 5, p. 399
- By:
- Publication type:
- Article
Breast cancer patients should not live without a HER-2/neu tissue result -- But how safe can they live with it?
- Published in:
- Wiener Klinische Wochenschrift, 2004, v. 116, n. 1/2, p. 3, doi. 10.1007/BF03040416
- By:
- Publication type:
- Article
Breast cancer and bone metastases: a call for appropriate treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e235822, doi. 10.1001/jamanetworkopen.2023.5822
- By:
- Publication type:
- Article
Association of IL-6, Hypothalamus-Pituitary-Adrenal Axis Function, and Depression in Patients With Cancer.
- Published in:
- Integrative Cancer Therapies, 2010, v. 9, n. 3, p. 270, doi. 10.1177/1534735410370036
- By:
- Publication type:
- Article
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 1, p. 128, doi. 10.1002/ijc.34912
- By:
- Publication type:
- Article
Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.
- Published in:
- Breast Cancer: Targets & Therapy, 2014, v. 6, p. 115, doi. 10.2147/BCTT.S61699
- By:
- Publication type:
- Article
ABC7 Consensus: Assessment by a German Group of Experts.
- Published in:
- Breast Care, 2024, v. 19, n. 2, p. 116, doi. 10.1159/000535997
- By:
- Publication type:
- Article
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS).
- Published in:
- Breast Care, 2022, v. 17, n. 5, p. 508, doi. 10.1159/000524984
- By:
- Publication type:
- Article
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.
- Published in:
- Breast Care, 2022, v. 17, n. 4, p. 421, doi. 10.1159/000524789
- By:
- Publication type:
- Article
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 336, doi. 10.1159/000517501
- By:
- Publication type:
- Article
ABC6 Consensus: Assessment by a Group of German Experts.
- Published in:
- Breast Care, 2022, v. 17, n. 1, p. 90, doi. 10.1159/000522068
- By:
- Publication type:
- Article
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer.
- Published in:
- Breast Care, 2021, v. 16, n. 2, p. 108, doi. 10.1159/000515701
- By:
- Publication type:
- Article
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts.
- Published in:
- Breast Care, 2020, v. 15, n. 1, p. 82, doi. 10.1159/000505957
- By:
- Publication type:
- Article
Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy – German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019).
- Published in:
- Breast Care, 2019, v. 14, n. 5, p. 315, doi. 10.1159/000502603
- By:
- Publication type:
- Article
What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?
- Published in:
- Breast Care, 2019, v. 14, n. 1, p. 10, doi. 10.1159/000496834
- By:
- Publication type:
- Article
Approval by Authorities Does Not Allow For Suboptimal Study Conduct but Offers New Academic Possibilities.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Management of HER2-Positive Early Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- Question & Answer
News from the San Antonio Breast Cancer Symposium 2017.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
ABC4 Consensus: Assessment by a German Group of Experts.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
ABC3 Consensus: Assessment by a German Group of Experts.
- Published in:
- 2016
- By:
- Publication type:
- Proceeding
News from the Advanced Breast Cancer Third International Consensus Conference (ABC3).
- Published in:
- 2015
- By:
- Publication type:
- Proceeding
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 355, doi. 10.1007/s10549-022-06795-x
- By:
- Publication type:
- Article
Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 495, doi. 10.1007/s10549-019-05262-4
- By:
- Publication type:
- Article
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
- Published in:
- 2020
- By:
- Publication type:
- journal article
What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5331, doi. 10.1007/s00432-022-04489-x
- By:
- Publication type:
- Article
Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays.
- Published in:
- 2022
- By:
- Publication type:
- Editorial